echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The world's most expensive drug Novartis SMA gene therapy Zolgensma is included in UK health insurance

    The world's most expensive drug Novartis SMA gene therapy Zolgensma is included in UK health insurance

    • Last Update: 2021-03-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the latest news, Novartis spinal muscular atrophy (SMA) gene therapy Zolgensma (onasemnogene abeparvovec) has been approved to be included in the British National Health Service (NHS).


    Novartis' gene therapy for spinal muscular atrophy, Zolgensma, is considered the most expensive drug in the world.


    Novartis Zolgensma is the first gene therapy to treat spinal muscular atrophy.


    Spinal muscular atrophy is a difficult disease in which the loss of specific gene function leads to a decrease in muscle strength.


    External analysis believes that Zolgensma has been successfully incorporated into the British medical insurance system, paving the way for the National Institute of Health and Clinical Optimization (NICE), the UK's price regulator, to finally approve the drug.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.